MWVC
AGN

Morgens Waterfall Vintiadis & Co’s Allergan plc AGN Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,000
Closed -$762K – 75
2018
Q3 		$762K Buy
+4,000
New +$735K 0.5% 43
2015
Q3 		– Sell
-10,500
Closed -$3.19M – 53
2015
Q2 		$3.19M Hold
10,500
– – 2% 22
2015
Q1 		$3.13M Hold
10,500
– – 2.01% 22
2014
Q4 		$2.7M Hold
10,500
– – 1.51% 25
2014
Q3 		$2.53M Buy
+10,500
New +$2.35M 1.78% 24

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's AGN Position: Q4 2018 in Review

Morgens Waterfall Vintiadis & Co sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 4,000 shares — an estimated $762K sold.

Morgens Waterfall Vintiadis & Co first reported a position in AGN in Q3 2014 and held it in 5 quarters. The position peaked at $3.19M in Q2 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Morgens Waterfall Vintiadis & Co reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 4,000 Allergan plc shares in Q4 2018, an estimated $762K.
  • Morgens Waterfall Vintiadis & Co first reported a position in Allergan plc in Q3 2014 and held it in 5 quarters.
  • Morgens Waterfall Vintiadis & Co's Allergan plc position peaked at $3.19M in Q2 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2018, filed 14 Feb 2019.